The two main themes of my address are, first, a resolution between the perceived conflict of research versus practice for the socially conscious pediatrician and, secondly, the particular role of the pediatrician as a researcher. To summarize my conclusions, research is socially acceptable and, indeed, necessary and to serve children it must be performed in part by you-pediatricians.
Being born in the waning days of World War 11, I received all of my higher education during the 1960s, that hopeful and tumultuous decade of the civil rights movement and the escalating Vietnam war. I saw medicine as a means to directly improve the health care of the underprivileged and, also, through the societal power and prestige of the physician, to have a disproportionate impact on social issues. Yet, a very significant part of me loved scientific research, pushing the boundaries of knowledge at bit further, glimpsing a new piece of truth, even if evanescent. I perceived a conflict between the direct caregiver, toiling in a ghetto clinic, who seemed to embody the compassionate, involved physician, and the cold, scientific researcher, sitting in his or her tower, surrounded by glassware and humming machines.
My years in research have definitely taught me that being a scientist does not mandate a lack of feelings or passion. Witness the discussions occurring with regularity at our meetings. More importantly, I began to appreciate the role of the researcher in the care of poor children, in an era of limited resources. It is the poor child in our society who bears the disproportionate burden of ill health. Be it the scourge of substance abuse, infections (including human immunodeficiency virus), teenage pregnancy, prematurity, or violence, the poor feel it the most. And in each of these areas, there are critical research questions, from the most basic molecular mechanisms to the broad societal area of health care delivery, all of which must be attacked in a rigorous fashion if we are to aid the poor child in a rational, effective, and efficient manner. Indeed, any research-based medical advance will disproportionately aid the poor child, inasmuch as it is that sector of our society that is so selectively burdened by ill health. The Society for Pediatric Research (SPR) state of the art symposium will be dedicated to the medical-social crisis in child health, and will highlight several of the problems we face and the role for research in helping to begin to solve these problems. I hope many of you will be in attendance. In fortuitous parallel, all of the American Medical Association journals this month are directed to the care of the poor. In particular, the American Journal of Diseases oJChildhood is devoted to care of the poor child. 1 have authored an invited paper on behalf of the SPR pointing out the critical role of research in the effort to address this pressing need (I) . The poor child is helped by both the clinician and the researcher. Surely, the time scale is different and fhe day to day Suppo~ted by Grants A12347 and HD13021 from the National Institutes of Health.
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proximity to the problem varies, but the results of both groups are critically necessary. Hopefully, as this nation reorders its priorities, the appearance of financial conflict between research programs and direct care programs will fall away. and enhanced cooperation will ensure the smooth transfer of technology that we so desperately need in this arena. What good is a recombinant vaccine based on the highest technology of immunology and genetic engineering if an irrational health care delivery system fails to deliver the goods to the highest need group.
For my colleagues who feel that third world medicine is a long flight away to exotic countries, I would urge them to take a short bus or subway ride to the bamo or ghetto where the infant mortality rates, the infectious disease rates, and other markers of third world life are very much in existence. In this setting, there is need and opportunity for the clinically active bench scientist, as well as the clinic-based caregiver. The intermingling of these talents will result in cross-fertilization and enhanced productivity. rigor, variety, and satisfaction.
Both bench work and clinic work are, in the end, of benefit to society. Any perceived conflict between these two is a pseudoconflict. Indeed, the wonderful flexibility of academic medicine allows me to work in the San Francisco General Hospital tuberculosis clinic in the morning and to study lymphocyte effector mechanisms in the afternoon.
The second area I would like to briefly address is, "Why the need for the pediatrician as a researcher?" We pediatricians have spent at least half of our medical school training, the bulk of a 3-year residency, and a fair portion of fellowship immersed in strictly clinically related education, which many would say doesn't add to research expertise. Wouldn't it be better, more efficient, to have most or all research performed by scientists unencumbered by the time restraints of clinical training periods and usually at least part-time clinical activities while they are doing their research? I would submit to you that there are several critical reasons for having pediatrician researchers.
Pediatricians first are interested in children. They look at a clinical situation and ask. "How can we help this child?" The same motivation is the core of their research. When I see a neonate with severe herpes, I want to know what converts a usually trivial viral infection into a lethal one in the newborn. The frustrations of the clinical arena, the limitations of our art, are the engines of motivation for our research. This is a very powerful engine indeed.
The pediatrician asks different questions. They are childrelated and often arise from our clinical experience. There are so many research questions to be answered that without the pediatrician asking the question I fear the answers for children would be very slow in coming. Well, then, why not let the pediatrician ask the questions and have someone else do the work? It is clear that the quality researcher likes to, and must, ask his or her own questions. We may start young people out in our laboratories 302 KOHL working in part on our area of inquiry, but their growth and ultimate quality will depend on their refinements of intimately personal research questions. The sustained effort needed to answer a significant pediatric question is generally only made by the pediatrician researcher.
A seemingly trivial but actually critical reason to have pediatrician scientists is their access to the relevant populations and samples. It is easier, except maybe in California, to work on animals than humans and infinitely easier to work with samples from adult animals or humans than with those from children. This barrier to working with children can be a daunting one. Yet, for the pediatrician, who has spent half his or her residency starting i.v.s and drawing blood from invisible veins of sick children, there is no barrier. Not only do we have access to the child population, but indeed we are the only ones with the key. Thus, we have a special responsibility to use this population and san~ples from it in a sensitive and ethical manner to answer pressing questions.
The pediatrician researcher helps the children he or she studies. By making significant discoveries, therapy is altered. That is obvious. But also the act of studying a question or a population usually in~proves the problem even with no new discoveries at all. To the researcher, this can be particularly frustrating, first by necessitating concomitant, not historical, control groups. Even more maddening is the all too frequent event of studying the question away altogether. How often have we heard that the incidence of a particular problem in the large study was much lower than in the historical group on which sample size was based? The focus upon a population subtly improves care, heightens concern, and does all the things that we as clinicians know will result in improved outcome. It has been absolutely fascinating for me to watch the improvements of outcome of neonatal enteric meningitis wrought by 15 years of study in a collaborative fashion without a significant change in antibiotic use (2) (3) (4) (5) .
Finally, one must look at the general impact of doing research on the individual and the field as a whole. The rigorous methods of modern research demand an exactness, adherence to a reliable data base, an acknowledgment of weakness, and doubt in our techniques, samples, and often results. Research indeed is predicated on an inherent and overtly recognized incompleteness in the field of study. These same qualities, camed over to the bedside in a nonneurotic fashion, result in humility and acknowledgment of our limitations as physicians, but also fierce adherence to what we know works and healthy skepticism of the anecdotal, of the tried and true but untested. The pediatrician scientist is thus the training role model of healthy doubt, aggressive inquiry, adherence to a reliable clinical data base, and rigorous patient care. Yet, his or her recognition of the limitations in the current data base induces a humility and desire to educate patients so that they may participate in an informed way in decision making.
In my area, the basic discovery of antibody-facilitated killing of herpes-infected cells by leukocytes known as antibody-dependent cellular cytotoxicity or ADCC was made in 1974 (6, 7) .
For 17 years, my research has been devoted to the role of ADCC in herpes simplex infections. It was only natural that as a pediatrician I should ask about the role of this mechanism in the neonate. We thus have demonstrated in vitro defects in the ability of lymphocytes from human neonates and infants to mediate anti-herpes simplex virus ADCC (8, 9) . To develop a relevant model, we uncovered a similar defect in infant mice (lo). Who else but a pediatrician and his or her staff would work with animals the size of the end of your thumb nail to answer a question? We have gone on to use the neonatal mouse model to support the in vivo relevance of human leukocyte ADCC in a xenogeneic transfer model ( 1 1, 12 ). In collaboration with other pediatricians, notably Don Anderson at Baylor College of Medicine, utilizing pediatric patient samples, we have probed the role of leukocyte adhesive glycoproteins in ADCC (13, 14) . Finally, we have begun to uncover relevant viral epitopes as ADCC targets in vitro and in vivo (1 5) and explore successful cytokine up-regulation of neonatal effector cell function (16 I would like to thank the council members, officers, and administrative staff of the SPR for the joy of working with a wonderful group of quality and dedicated people. I would like to thank the membership of the SPR, which has allowed me this privilege and provided me with the colleagues that make this all worthwhile. Finally, I would like to thank my wife, Sybil, and my daughter, Gwynne, for their love and support.
In closing, I shall paraphrase a Hebrew meditation, "Cherish doubt, it is the handmaiden of truth, the servant of discovery, the acid which eats away the false. They that fear not doubt are founded on a rock." And, in my words, don't worry about the current relevance of your discoveries; if it is true, it will become relevant sooner than you think. And have fun in your worklife is too short not to.
Thank you all.
